News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
550,562 Results
Type
Article (35994)
Company Profile (387)
Press Release (514172)
Multimedia
Podcasts (112)
Webinars (18)
Section
Business (144614)
Career Advice (642)
Deals (25242)
Drug Delivery (102)
Drug Development (65843)
Employer Resources (96)
FDA (13067)
Job Trends (11949)
News (252052)
Policy (25406)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (3)
Academia (2394)
Academic (2)
Accelerated approval (31)
Adcomms (20)
Allergies (129)
Alliances (39326)
ALS (157)
Alzheimer's disease (1512)
Antibody-drug conjugate (ADC) (285)
Approvals (13351)
Artificial intelligence (496)
Autoimmune disease (140)
Automation (26)
Bankruptcy (216)
Best Places to Work (10432)
BIOSECURE Act (13)
Biosimilars (171)
Biotechnology (270)
Bladder cancer (135)
Brain cancer (55)
Breast cancer (561)
Cancer (4264)
Cardiovascular disease (376)
Career advice (591)
Career pathing (18)
CAR-T (259)
CDC (53)
Cell therapy (683)
Cervical cancer (34)
Clinical research (56257)
Collaboration (1630)
Company closure (2)
Compensation (687)
Complete response letters (46)
COVID-19 (2577)
CRISPR (94)
C-suite (792)
Cystic fibrosis (139)
Data (5700)
Decentralized trials (2)
Denatured (32)
Depression (140)
Diabetes (441)
Diagnostics (5601)
Digital health (51)
Diversity (11)
Diversity, equity & inclusion (28)
Drug discovery (247)
Drug pricing (179)
Drug shortages (15)
Duchenne muscular dystrophy (230)
Earnings (54773)
Editorial (54)
Employer branding (11)
Employer resources (88)
Events (100135)
Executive appointments (919)
FDA (15908)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1418)
Gene editing (204)
Generative AI (49)
Gene therapy (565)
GLP-1 (826)
Government (4706)
Grass and pollen (7)
Guidances (332)
Healthcare (17805)
HIV (55)
Huntington's disease (44)
IgA nephropathy (82)
Immunology and inflammation (226)
Immuno-oncology (51)
Indications (101)
Infectious disease (2848)
Inflammatory bowel disease (186)
Inflation Reduction Act (16)
Influenza (118)
Intellectual property (211)
Interviews (73)
IPO (12069)
IRA (44)
Job creations (1941)
Job search strategy (522)
JPM (66)
Kidney cancer (10)
Labor market (52)
Layoffs (379)
Leadership (16)
Legal (4734)
Liver cancer (77)
Longevity (15)
Lung cancer (559)
Lymphoma (323)
Machine learning (35)
Management (33)
Manufacturing (587)
MASH (158)
Medical device (10382)
Medtech (10428)
Mergers & acquisitions (14121)
Metabolic disorders (1148)
Multiple sclerosis (145)
NASH (15)
Neurodegenerative disease (296)
Neuropsychiatric disorders (89)
Neuroscience (2688)
Neurotech (1)
NextGen: Class of 2026 (5864)
Non-profit (4221)
Now hiring (41)
Obesity (533)
Opinion (230)
Ovarian cancer (152)
Pain (167)
Pancreatic cancer (196)
Parkinson's disease (264)
Partnered (27)
Patents (396)
Patient recruitment (437)
Peanut (55)
People (46869)
Pharmaceutical (63)
Pharmacy benefit managers (30)
Phase 1 (18711)
Phase 2 (24537)
Phase 3 (17967)
Pipeline (4767)
Policy (274)
Postmarket research (1880)
Preclinical (7682)
Press Release (56)
Prostate cancer (217)
Psychedelics (55)
Radiopharmaceuticals (277)
Rare diseases (816)
Real estate (3645)
Recruiting (41)
Regulatory (19951)
Reports (29)
Research institute (2271)
Resumes & cover letters (57)
Rett syndrome (26)
RNA editing (21)
RSV (67)
Schizophrenia (147)
Series A (237)
Series B (185)
Service/supplier (4)
Sickle cell disease (98)
Special edition (21)
Spinal muscular atrophy (144)
Sponsored (32)
Startups (3032)
State (1)
Stomach cancer (7)
Supply chain (78)
Tariffs (56)
The Weekly (79)
Vaccines (975)
Venture capital (92)
Weight loss (329)
Women's health (88)
Worklife (9)
Date
Last 7 days (524)
Last 30 days (1786)
Last 365 days (26613)
2026 (3060)
2025 (27038)
2024 (31103)
2023 (34760)
2022 (45127)
2021 (48766)
2020 (47183)
2019 (40268)
2018 (30133)
2017 (24912)
2016 (24592)
2015 (28855)
2014 (21697)
2013 (16909)
2012 (17703)
2011 (18239)
2010 (16606)
Location
Africa (581)
Alabama (80)
Alaska (6)
Arizona (222)
Arkansas (13)
Asia (31042)
Australia (5473)
California (9730)
Canada (2933)
China (1000)
Colorado (406)
Connecticut (418)
Delaware (306)
Europe (69502)
Florida (1409)
Georgia (363)
Hawaii (4)
Idaho (50)
Illinois (770)
India (62)
Indiana (492)
Iowa (16)
Japan (379)
Kansas (118)
Kentucky (32)
Louisiana (26)
Maine (83)
Maryland (1240)
Massachusetts (7405)
Michigan (252)
Minnesota (522)
Mississippi (4)
Missouri (125)
Montana (23)
Nebraska (21)
Nevada (99)
New Hampshire (63)
New Jersey (2684)
New Mexico (21)
New York (2634)
North Carolina (1306)
North Dakota (8)
Northern California (4797)
Ohio (306)
Oklahoma (20)
Oregon (39)
Pennsylvania (2019)
Puerto Rico (14)
Rhode Island (44)
South America (750)
South Carolina (40)
South Dakota (1)
Southern California (3750)
Tennessee (152)
Texas (1505)
United States (35376)
Utah (289)
Virginia (225)
Washington D.C. (67)
Washington State (865)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
550,562 Results for "emerald health therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules
Australia’s Department of Health has issued import permits for Optimi’s MDMA and psilocybin capsules for use under the Authorised Prescriber Scheme
January 26, 2026
·
1 min read
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Press Releases
OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications
October 30, 2025
·
6 min read
Press Releases
PTC Therapeutics Announces Health Canada Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU)
December 10, 2025
·
3 min read
Press Releases
Fractyl Health Enters a Catalyst-Rich 2026 Positioned to Define the Post-GLP-1 Weight Maintenance Therapeutic Category
January 5, 2026
·
8 min read
Press Releases
Syremis Therapeutics Launches with $165M to Develop Best-in-Class Medicines for Mental Health Conditions
December 19, 2025
·
4 min read
Deals
Skye Bioscience Closes Acquisition of Emerald Health Therapeutics
Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, has concluded the merger transaction with Emerald Health Therapeutics (“Emerald”). Both companies’ shareholders voted in favor of the transaction and the Supreme Court of British Columbia approved the transaction.
November 11, 2022
·
17 min read
Press Releases
Mallinckrodt Completes Spin-Off of Par Health, Introduces Keenova Therapeutics
November 10, 2025
·
11 min read
Press Releases
SiPhox Health Introduces a Smarter Way of Health Tracking From Home
February 3, 2026
·
1 min read
Press Releases
Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therapeutic Potential of MCS-8 in Oncology and Metabolic Health, Alongside Strategic Market Entry into Asia
February 12, 2026
·
8 min read
1 of 55,057
Next
